These beneficial effects could be related to the ability of ucp3 to promote mitochondrial uncoupling and control ROS production and suggest that uncoupling proteins might represent novel therapeutic targets in patients with coronary artery disease. This evidence concerns the gene UCP3 and coronary artery disorder.